arrow
Back
A

André Scheen

universite clermont auvergne

81H-index
1.5KPaper Count
3.7WCitation Count
Published Papers 139
Publication Date
Impact of high intensity physical activity compared to routine counseling on renal function decline in patients with type 2 diabetes at high risk for kidney disease-the ACTIDIANE randomized controlled trial
err2026-07-01
err0
PREAI
errHadjadj, Samy; Ragot, Stephanie; Durocher, Lisa; Bigot-Corbel, Edith; Kessler, Laurence; Tauveron, Igor; Vidal-Trecan, Tiphaine; Saulnier, Pierre Jean; Gourdy, Pierre; Moret, Myriam; Rigalleau, Vincent; Borot, Sophie; Ducluzeau, Pierre Henri; Ciangura, Cecile; Paquot, Nicolas; Vambergue, Anne; Chevaliers, Nicolas; Carette, Claire; Monier, Arnaud; Bohme, Philip; Pernfornis, Alfred; Verges, Bruno; Morcel, Pierre; Gautier, Jean Francois; Halimi, Jean-Michel; Henrya, Patrick; Marre, Michel; Scheen, Andre; Duclos, Martine; Bosquet, Laurent; Cariou, Bertrand
errShare
errSave
Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes
err2022-10-11
err3
errOAAI
errSanchez, Manuel; Kannengiesser, Caroline; Hoang, Sophie; Potier, Louis; Fumeron, Frederic; Venteclef, Nicolas; Scheen, Andre; Gautier, Jean-Francois; Hadjadj, Samy; Marre, Michel; Roussel, Ronan; Mohammedi, Kamel; Velho, Gilberto
errShare
errSave
When therapeutic drugs lead to diabetes
err2022-03-04
err16
errOAAI
errFeve, Bruno; Scheen, Andre J.
errShare
errSave
Sodium-glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria
err2021-06-11
err16
errOAAI
errDelanaye, Pierre; Wissing, Karl Martin; Scheen, Andre J.
errShare
errSave
ACE I/D Polymorphism, Plasma ACE Levels, and Long-term Kidney Outcomes or All-Cause Death in Patients With Type 1 Diabetes
err2021-04-07
err4
errOAAI
errAbouleka, Yawa; Mohammedi, Kamel; Carpentier, Charlyne; Dubois, Severine; Gourdy, Pierre; Gautier, Jean-Francois; Roussel, Ronan; Scheen, Andre; Alhenc-Gelas, Francois; Hadjadj, Samy; Velho, Gilberto; Marre, Michel
errShare
errSave
Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy Secondary Analysis From the FOURIER Randomized Clinical Trial
err2021-02-01
err52
errOAAI
errDeedwania, Prakash; Murphy, Sabina A.; Scheen, Andre; Badariene, Jolita; Pineda, Armando Lira; Honarpour, Narimon; Keech, Anthony C.; Sever, Peter S.; Pedersen, Terje R.; Sabatine, Marc S.; Giugliano, Robert P.
errShare
errSave